- Lobbying
- Danielle AND Peters AND Mrs
Lobbying Arrangements Results for 'Danielle Peters Mrs'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Government partnerships for drug development software |
Fabiani & Company on behalf of Scynexis
|
Mrs. Danielle Organ Peters | |||
Details Raise awareness about company's Accelerated Development and Manufacturing (ADM) Center and network |
Nanotherapeutics, Inc.
|
Mrs. Danielle Organ Peters | |||
Details Funding and partnerships with the Department of Defense for wound healing research and development |
Fabiani & Company on behalf of TherOx, Inc.
|
Mrs. Danielle Organ Peters | |||
Details Funding for novel antibiotics research and development |
Fabiani & Company on behalf of Crestone Inc.
|
Mrs. Danielle Organ Peters | |||
Details Funding for biopharmaceutical product development and manufacturing |
Fabiani & Company on behalf of Planet Biotechnology Inc.
|
Mrs. Danielle Organ Peters | |||
Details Generating Antibiotic Incentives Now (GAIN) Act |
Fabiani & Company on behalf of Trius Therapeutics
|
Mrs. Danielle Organ Peters | |||
Details Department of Defense Appropriations Act of 2009, provisions relating to Army funding for medical research |
Fabiani & Company on behalf of VaxInnate
|
Mrs. Danielle Organ Peters | |||
Details Pursuing government funding to support therapeutic platform development for infectious diseases |
Fabiani & Company on behalf of 3-V Biosciences
|
Mrs. Danielle Organ Peters | |||
Details Research, development and manufacture of hemoglobin-derived therapeutics |
Fabiani & Company on behalf of Therapure Biopharma
|
Mrs. Danielle Organ Peters | |||
Details Federal funding for Research and Development |
Fabiani & Company on behalf Alnylam Pharmaceuticals
|
Mrs. Danielle Organ Peters | |||
Details Public policy to incentivize antibiotic drug development and innovation |
The Conafay Group on behalf of Antibiotics Working Group
|
Mrs. Danielle Organ Peters | |||
Details Educated members of the House of Representatives on the importance of encouraging innovation in rare cancer drug development. |
The Conafay Group on behalf of Ziopharm Oncology, Inc.
|
Mrs. Danielle Organ Peters | |||
Details Federal funding to support development of biopharmaceutical products to treat military and civilian populations |
Fabiani & Company on behalf of Arca biopharma Inc
|
Mrs. Danielle Organ Peters | |||
Details Research and development of novel vaccines for pandemic influenza |
Fabiani & Company on behalf of Medicago
|
Mrs. Danielle Organ Peters | |||
Details Research & Development and Commercialization of an influenza vaccine |
The Conafay Group, LLC on behalf of Medicago
|
Mrs. Danielle Organ Peters | |||
Details Drug development for TBI/stroke related conditions |
Fabiani & Company on behalf of Concert Pharmaceuticals
|
Mrs. Danielle Organ Peters | |||
Details Cell therapy delivery research |
Fabiani & Company on behalf of MEDRAD Inc.
|
Mrs. Danielle Organ Peters | |||
Details Countermeasures for chemical defense Funding for flexible manufacturing to address public health emergencies |
Fabiani & Company on behalf of Nanotherapeutics Inc.
|
Mrs. Danielle Organ Peters | |||
Details Funding and parnerships with the Department of Defense for vaccine research and development Funding and parnerships with the Department of Defense and Department of Health and Human Services for va... |
Fabiani & Company on behalf of Variation Biotechnologies
|
Mrs. Danielle Organ Peters | |||
Details MED HCR |
Medicago Inc.
|
Magnet Strategy Group | |||
Details Fiscal Year 2010 Defense Appropriations Act. Funding for biopharmaceutical product trials for treatment to address long term health impact of substance abuse in military populations. Funding for bi... |
Fabiani & Company on behalf of Ocera Therapeutics Inc.
|
Mrs. Danielle Organ Peters |